Digital lifestyle intervention to prevent cardiovascular disease
Official title: A Digital Lifestyle Intervention in Primary Healthcare to Prevent Cardiovascular Disease
Run by Karolinska Institutet · NCT06847633 · Data updated 2026-11-12
This study tests if a digital program can help people aged 40-60 in Sweden make healthier lifestyle choices to prevent heart disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 39 Years to 61 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 6 sites (Gävle and 5 other locations) |
| Status | Recruiting |
| Started | March 3, 2025 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | June 9, 2026 |
| Trial ID | NCT06847633 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 40-60 who are willing to change at least one lifestyle behavior related to physical activity, diet, smoking, alcohol, sleep, or stress.
✕Probably not a fit
Patients with diabetes, heart failure, a history of myocardial infarction, a history of stroke, or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project evaluates a digital lifestyle intervention designed to improve cardiovascular health outcomes and lifestyle behaviors among patients aged 40-60 in Swedish primary healthcare. Participants will be randomized into either a control group receiving standard care or an intervention group receiving the digital lifestyle program. The intervention aims to leverage digital tools to support healthier lifestyle choices and ensure sustained implementation within the healthcare system. The study will assess the effectiveness of this approach in a multi-center randomized controlled trial format.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the risk of cardiovascular disease by promoting healthier lifestyle choices among patients.
How similar studies have gone: Other studies have shown success with digital lifestyle interventions in improving health outcomes, indicating that this approach is promising and not entirely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Attended a Health dialogue visit to primary healthcare for patients 40-60 years old * Willing to change at least one lifestyle behavior regarding physical activity, diet, smoking/snus, alcohol, sleep, or stress Exclusion Criteria: * diabetes * heart failure * history of myocardial infarction * history of stroke * pregnancy
Where it's running
-
Primary healthcare centers in Region Halland
Halmstad, Sweden Recruiting -
Primay healthcare centers in Region Östergötland
Linköping, Sweden Recruiting -
Primary healthcare centers in region Skåne
Malmö, Sweden Recruiting -
Primary healthcare centers in Region Västerbotten
Umeå, Sweden Recruiting -
Primary healthcare centers in Region Västmanland
Västerås, Sweden Recruiting -
Primary helathcare centers in Region Gävleborg
Gävle, Sweden Not yet recruiting
Study contacts
- Principal investigator: Marie Löf, PhD — Karolinska Institutet
- Study coordinator: Linnea Hedin, PhD
- Email: linnea.hedin@ki.se
- Phone: +4670-2473149
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving heart health through AI text messaging
This study is testing whether different types of text messages, including ones from an AI chatbot and support from a pharmacist, can help people at higher risk for heart disease improve their heart health.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.